Academic-Industrial Relationships in the Life Sciences

New England Journal of Medicine

Volumn 349, Issue 25, 2003, Pages 2452-2459

  Blumenthal, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; GOVERNMENT; INDUSTRY; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; SCIENCE; UNITED STATES; UNIVERSITY;

BIOMEDICAL AND BEHAVIORAL RESEARCH; LEGAL APPROACH;

BIOLOGICAL SCIENCES; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; INDUSTRY; INTERINSTITUTIONAL RELATIONS; NATIONAL INSTITUTES OF HEALTH (U.S.); RESEARCH; RESEARCH SUPPORT; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; UNIVERSITIES;

EID: 0346234415     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMhpr035460     Document Type: Review

References (47)

1. Vogel G. FDA moves against Penn scientist Science 2000;290: 2049-51.
2. Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress. II. Principles and recommendations for oversight of an institution's financial interests in human subjects research. Washington, D.C.: Association of American Medical Colleges, October 2002.
3. Blumenthal D. Academic-industry relationships in the life sciences: extent, consequences, and managemenr. JAMA 1992;268: 3344-9.
4. Swann JP. Academic scientists and the pharmaceutical industry cooperative research in twentieth-century America. Baltimore: Johns Hopkins University Press, 1988.
5. Culliton BJ. The academic-industrial complex. Science 1982; 216:960-2.
6. Government-University-Industry Research Roundtable. New alliances and partnerships in American science and engineering. Washington, D.C.: National Academy Press, 1986.
7. Culliton BJ. Pajaro Dunes: the search for consensus. Science 1982;216:155-6, 158.
8. Bok DC. Universities in the marketplace: the commercialization of higher education. Princeton, N.J.: Princeton University Press, 2003.
9. Lanfitt TW, Hackney S, Fishman AP, Glowasky AV, eds. Partners in the research enterprise: university-corporate relations in science and technology. Philadelphia: University of Pennsylvania Press, 1983.
10. Gore A Jr. Recombinated institutions: the changing university-corporate relationship. In: Langfitt TW, Hackney S, Fishman AP, Glowasky AV, eds. Partners in the research enterprise: university-corporate relations in science and technology. Philadelphia: University of Pennsylvania Press, 1983:121-7.
11. Committee on Science, Space and Technology, U.S. House of Representatives. Hearing before the Technology Policy Task Force. 100th Congress. July 29, 1987. Washington, D.C.: Government Printing Office, 1987.
12. Committee on Government Operations, U.S. House of Representatives. Are scientific misconduct and conflicts of interest hazardous to our health? Nineteenth report by the Committee on Government Operations. Washington, D.C.: Government Printing Office, 1990.
13. Wyngaarden JB. Government, industry, and academia: a Bermuda triangle? In: Langfitt TW, Hackney S, Fishman AP, Glowasky AV, eds. Partners in the research enterprise: university-corporate relations in science and technology. Philadelphia: University of Pennsylvania Press, 1983:128-38.
14. Grobstein C. Biotechnology and open university science. Sci Technol Hum Values 1985;10:55-63.
15. Peters LS, Fusfeld HI. Current U.S. university/industry research connections. Washington, D.C.: National Science Board, 1982.
16. Blumenthal D, Gluck M, Louis KS, Stoto MA, Wise D. University-industry relationships in biotechnology: implications for the university. Science 1986;232:1361-6.
17. Levine J. Technology tales: five case studies explore one question: Johns Hopkins moves into the marketplace, but at what price? Johns Hopkins Magazine. August 1990:14-31.
18. Blumenthal D, Campbell EG. Academic-industry relationships in biotechnology, overview. In: Murray TH, Mehlman MJ, eds. Encyclopedia of ethical, legal and policy issues in biotechnology. New York: John Wiley, 2000.
19. Pressman L. AUTM Licensing Survey, FY 1999 Survey Summary. Northbrook, Ill.: Association of University Technology Managers, 2000.
20. Strickland SP. Politics, science, and dread disease: a short history of the United States medical research policy. Cambridge, Mass.: Harvard University Press, 1972.
21. Prager DJ, Omenn GS. Research, innovation, and university-industry linkages. Science 1980;207:379-84.
22. Dickson D. The new politics of science. New York: Pantheon Books, 1984.
23. Technology transfer: administration of the Bayh-Dole Act by research universities. Washington, D.C.: General Accounting Office, 1998. (GAO publication no. B-275266.)
24. Keyworth GA II. Federal R and D and industry policy. Science 1983; 220:1122-5.
25. Eveland JD, Hetzner W. Development of university-industry cooperative research centers: historical profiles. Washington, D.C.: National Science Foundation, 1982.
26. Etzkowitz H. The rise of the entrepreneurial university. (http:// www.center.kva.se/NS123/Paper%/EtzkowitzPaper.pdf.)
27. Blumenthal D, Campbell EG, Causino N, Louis KS. Participation of life-seience faculty in research relationships with industry. N Engl J Med 1996;335:1734-9.
28. Commonwealth Fund Task Force on Academic Health Centers. From bench to bedside: preserving the research mission of academic health centers. New York: Commonwealth Fund, 1999.
29. Cohen W, Florida R, Goe WR. University-industry research centers in the United States. Pittsburgh: Carnegie Mellon University, 1994.
30. Campbell EG, Powers JB, Blumenthal D, Biles B. Inside the triple helix: government, university and industry technology transfer and commercialization in the life sciences. Health Aff (Millwood) (in press).
31. Dorfman NS. Route 128: the development of a regional high technology economy. Res Policy 1983;12:299-316.
32. Jaffe AB, Trajtenberg M, Henderson R. Geographic localization of knowledge spillovers as evidenced by patent citations. QJ Econ 1993;108:577-98.
33. Newman M. San Diego's spreading biotechnology colony. New York Times. April 9, 2003:C6.
34. Leonhardt D. Growing health care economy gives Northeast a needed boost. New York Times. December 30, 2002:A1.
35. Frist W. Gene therapy: is there oversight for patient safety: opening statement to the Senate Subcommittee on Public Health, February 2, 2000. (http://frist.senate.gov/press-item.cfm?id=184785.)
36. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-65.
37. Blumenthal D, Causino N, Campbell EG, Louis KS. Relationships between academic institutions and industry in the life sciences - an industry survey. N Engl J Med 1996;334:368-73.
38. Campbell EG, Clarridge BR, Gokhale M, et al. Data-withholding in academic genetics: evidence from a national survey. JAMA 2002;287:473-80.
39. Nathan DG, Weatherall DJ. Academic freedom in clinical research. N Engl J Med 2002;347:1368-71.
40. Rennie D. Thyroid storm. JAMA 1997;277:1238-43. [Erratum, JAMA 1997;277:1762.]
41. Rennie D. Thyroid storm. JAMA 1997;277:1238-43. [Erratum, JAMA 1997;277:1762.]
42. Biomedical research: HHS direction needed to address financial conflicts of interest. Washington, D.C.: General Accounting Office, November 2001. (GAO-02-89.)
43. Cho MK, Shohara R, Schissel A, Rennie D. Policies on faculty conflicts of interest at US universities. JAMA 2000;284:2203-8.
44. Task Force on Financial Conflicts of Interest in Clinical Research. Protecting subjects, preserving trust, promoting progress - policy and guidelines for the oversight of individual financial interests in human subjects research. Washington, D.C.: Association of American Medical Colleges, December 2001.
45. Task Force on Research Accountability. Report on university protections of human beings who are the subjects of research. Washington, D.C.: Association of American Universities, June 2000.
46. Association for the Accreditation of Human Subjects Research Protection Programs (AAHRPP) home page. (Accessed October 22, 2003, at http://www.aahrpp.org.)
47. Department of Health and Human Services. Financial relationships and interests in research involving human subjects: guidance for human subject protection. Fed Regist 2003;68(61):15456.